IOL Chemicals & Pharmaceuticals

89.44
+1.32
(1.50%)
Market Cap
2,586.60 Cr
EPS
22.90
PE Ratio
25.99
Dividend Yield
4.47 %
Industry
Healthcare
52 Week High
107.54
52 Week Low
57.50
PB Ratio
1.56
Debt to Equity
0.04
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,699.80
#1 3,99,825.20
35.55
#1 49,887.20
12.06
#1 9,648
-18.99
45.69
6,631.50
1,76,164.90
80.38
8,184.00
0.89
1,600
23.05
64.51
1,476.90
1,18,598.30
22.62
26,520.70
14.17
4,155
30.28
46.70
3,161.10
1,07,148.40
55.56
10,785.70
11.59
1,656
10.91
42.78
1,248.20
1,03,689.40
#1 18.42
28,905.40
12.36
5,578
21.14
66.73
2,461.80
1,02,476.30
51.21
10,615.60
19.57
1,942
-10.91
48.11
924.75
93,137.00
19.92
19,831.50
13.82
3,831
-0.19
61.49
1,970.10
88,642.00
27.40
20,141.50
#1 19.94
1,936
#1 112.49
44.46
1,172.90
66,664.40
19.71
29,559.20
17.55
3,169
-0.50
47.14
30,350.00
64,002.90
45.58
6,097.20
10.80
1,201
27.83
49.13
Forecast
Actual
Growth Rate
Revenue Growth
-3.56 %
Net Income Growth
-3.38 %
Cash Flow Change
137.25 %
ROE
-9.64 %
ROCE
-10.38 %
EBITDA Margin (Avg.)
7.59 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
579
570
547
530
596
570
552
529
511
510
532
527
532
Expenses
527
509
510
481
492
491
481
476
454
451
484
476
465
EBITDA
52
61
37
49
104
80
71
53
57
59
48
51
67
Operating Profit %
8 %
10 %
6 %
8 %
16 %
13 %
12 %
9 %
10 %
10 %
8 %
9 %
12 %
Depreciation
11
11
11
12
12
14
16
16
16
17
18
19
19
Interest
2
3
4
5
5
4
4
4
3
2
4
5
4
Profit Before Tax
39
47
22
33
87
61
51
32
37
40
26
28
45
Tax
9
12
6
9
22
15
13
9
10
10
7
7
13
Net Profit
30
35
16
24
65
46
38
23
28
30
19
21
31
EPS in ₹
5.07
5.91
2.71
4.05
11.03
7.81
6.45
3.93
4.71
5.11
3.26
3.50
1.07

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
1,962
2,022
2,244
Fixed Assets
561
752
933
Current Assets
1,081
920
1,120
Capital Work in Progress
105
90
101
Investments
2
20
20
Other Assets
1,294
1,161
1,190
Total Liabilities
1,962
2,022
2,244
Current Liabilities
513
456
560
Non Current Liabilities
57
58
73
Total Equity
1,392
1,508
1,612
Reserve & Surplus
1,334
1,449
1,553
Share Capital
59
59
59

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
-29
-2
6
Investing Activities
-121
-120
-191
Operating Activities
93
122
290
Financing Activities
-2
-4
-93

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
52.62 %
52.62 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.34 %
2.18 %
1.41 %
1.39 %
1.63 %
1.49 %
1.47 %
DIIs
0.04 %
0.04 %
0.36 %
0.50 %
0.02 %
0.02 %
0.06 %
0.17 %
0.02 %
0.26 %
0.36 %
0.37 %
0.30 %
0.10 %
0.08 %
0.08 %
0.07 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.30 %
28.03 %
29.86 %
30.15 %
30.29 %
31.15 %
31.15 %
30.92 %
30.49 %
29.28 %
30.28 %
30.63 %
30.98 %
31.48 %
31.31 %
31.23 %
31.43 %
Others
28.97 %
28.24 %
26.08 %
25.66 %
25.99 %
25.14 %
25.10 %
25.23 %
21.30 %
22.26 %
18.84 %
18.62 %
19.12 %
18.84 %
18.79 %
14.58 %
14.40 %
No of Share Holders
1,09,092
1,27,893
1,42,022
1,45,041
1,46,437
1,48,907
1,45,692
1,43,327
1,40,177
1,26,004
1,35,397
1,34,235
1,30,003
1,28,689
1,25,979
1,26,701
1,30,002

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 3 6 4 4 5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 2.72 8.48 7.07 5.53 8.18 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2025 77.10 88.12
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 65.00 77.10
27 Dec 2024 SPLIT Split
2:10
11 Mar 2025 82.27 82.27
18 Feb 2025 DIVIDEND Dividend
₹ 4.00 /share
18 Feb 2025 73.57 68.18
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 72.62 73.57
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 79.07 74.06
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 74.72 93.30
16 Feb 2024 DIVIDEND Dividend
₹ 5.00 /share
16 Feb 2024 87.56 82.25
17 Feb 2023 DIVIDEND Dividend
₹ 4.00 /share
17 Feb 2023 62.59 63.30
16 Feb 2022 DIVIDEND Dividend
₹ 4.00 /share
15 Feb 2022 91.71 77.42
12 Sept 2021 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2021 142.80 110.43

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated 16Th May 2025May 16, 2025
Audited Financial Results For The Quarter And Year Ended 31St March 2025May 16, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2025
Board Meeting Intimation for Notice Of The Board MeetingMay 06, 2025
Intimation Under SEBI (LODR) Regulations 2015 - CDE China Approved IbuprofenApr 28, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 03, 2025
Closure of Trading WindowMar 26, 2025
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2025
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 20, 2025
Corporate Action-Updates on intimation of Sub division / Stock SplitMar 13, 2025
EDQM Issued CEP Certificate For QUETIAPINE FUMARATEMar 05, 2025
Corporate Action-Updates on intimation of Sub division / Stock SplitMar 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Intimation On Communication To Members Regarding Tax Deduction At SourceFeb 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Corporate Action-Board approves DividendFeb 12, 2025
Board Meeting Outcome for Outcome Of The Board MeetingFeb 12, 2025
Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Corporate Action-Intimation of Sub division / Stock SplitFeb 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Board Meeting Intimation for Notice Of The Board MeetingFeb 04, 2025
Intimation Of Amendment To The Memorandum Of Association Of The CompanyJan 31, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 31, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 31, 2025
EDQM Issued CEP Certificate For MESALAZINEJan 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 02, 2025
Board Comments On Fine Levied By The ExchangeDec 27, 2024
Board Meeting Outcome for Outcome Of The Board MeetingDec 27, 2024
Closure of Trading WindowDec 18, 2024
Board Meeting Intimation for Notice Of The Board Meeting And Closure Of Trading WindowDec 18, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 18, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportDec 13, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotDec 13, 2024
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 29, 2024

Technical Indicators

RSI(14)
Neutral
78.36
ATR(14)
Less Volatile
3.64
STOCH(9,6)
Overbought
89.47
STOCH RSI(14)
Overbought
99.02
MACD(12,26)
Bullish
1.39
ADX(14)
Strong Trend
36.00
UO(9)
Bearish
58.31
ROC(12)
Uptrend But Slowing Down
34.60
WillR(14)
Overbought
-6.20

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Bandhan BSE Healthcare Index Fund Direct-Growth
1630
0.06%
0.00%
0.00%
Apr 2025
Bandhan Nifty Total Market Index Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Groww Nifty Total Market Index Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025